Opyl Limited announced that Tony Guoga and Mark Simari have been appointed Non-Executive Directors of the company, effective September 4, 2023. Tony Guoga joins Opyl as Non-Executive Director, bringing significant global technology expertise and European regulation experience. Mark Simari joins Opyl as Non-Executive Director, bringing over 15 years of Board and senior leadership experience across the Australian healthcare industry.

Dr. Megan Robertson resigns as Non-Executive Director of Opyl, effective September 4, 2023, due to competing commitments and to pursue other business interests. Tony Guoga is a renowned investor, technology entrepreneur, philanthropist and former member of the European parliament for Lithuania (2014-2019). Tony has extensive technology sector experience across start-ups, business development, management, venture capital and is a strong advocate for innovation and entrepreneurship.

He is currently Chairman of Canadian listed Cypherpunk Holdings Inc. (CSE: HODL, OTC: CYFRF), and a former Non- Executive Director of Echo IQ Limited (ASX:EIQ). During Tony's time in European parliament, he was an instrumental member of the European People's Party Group and worked on a range of digital policies in the Internal Market and Consumer Protection Committee. Mark Simari is an experienced and accomplished professional in the Australian health industry, with over 15 years of Board experience across a diverse range of ASX-listed organisations, as well as demonstrable track records of driving growth and profitability as a healthcare executive.

Mark was the former co-founder and managing director of Paragon Care and was instrumental in Paragon Care becoming independent healthcare suppliers in Australia and New Zealand, and during his leadership grew its market capitalisation from $2m to over $200m. Mark is also currently Chairman of IDT Limited, Careteq Limited and TALi Digital Limited.